American Journal of Psychiatry Audio

Amandeep Jutla, M.D., joins Dr. Dixon and Dr. Berezin, with guest host Dr. Matt Hirschtritt, to discuss concerns surrounding the use of large language model chatbots and psychiatric risk.
01:08   Introduction
04:03   Language models in 2019
05:18   The appeal of chat-based AI for autistic adults
07:34   Do you use chat-based AI models personally?
09:44   Specific concerns of interacting with AI chat bots
11:07   The illusion of speaking with a person
13:34   Suggestions for clinicians and researchers
16:17   Questions a clinician should ask
18:29   Uses for AI models
20:11   Can chat bots get good at providing advice?
21:30   Regulations?
24:12   Motivational interviewing
 
Transcript
 
Subscribe to the podcast here.
Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections.
Browse other articles on our website.
Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it.
Listen to other podcasts produced by the American Psychiatric Association.
Follow the journal on Twitter.

E-mail us at psjournal@psych.org

Dr. Deepak Cyril D'Souza (Yale University School of Medicine) joins the podcast to discuss a study looking at two cohorts of patients hospitalized with first instances of psychosis, one with cannabis exposure and one without. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the August issue of the Journal, which takes a look at issues surrounding schizophrenia spectrum disorder, from the clinical to basic science.
00:40     D'Souza interview
02:38     Subtyping and schizophrenia spectrum disorder
04:19     Relapse and long-term implications for cannabis induced psychosis
05:43     Improvements in cognition
08:03     Differences between the groups
09:26     Greater access and greater potency of cannabis products
11:29     Further research
13:45     Kalin interview
13:59     D'Souza et al.
21:34     Forsyth et al.
27:36     Enwright et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org

Dr. Dilip Jeste (Social Determinants of Health Network, La Jolla, CA) joins the podcast to discuss how social determinants of health interact with treatment for psychiatric disorders.  Afterwards, AJP Editor-in-Chief Dr. Ned Kalin once again puts the rest of the July issue into context.
00:31     Impacts of social determinants of health on psychiatric disorders, research, and clinical care
04:43     Health related social needs versus social determinants of health
08:47     Loneliness as a risk factor
12:36     A clinician's role in societal factors
14:47     Mechanistic understandings social determinants and the exposome
18:17     Further research
22:25     Kalin interview
22:30     Jeste and Gyan
23:33     Blundell et al.
28:03     Yang et al.
32:20     Van der Meer et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org

Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation.  AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression.
01:20     Tucciarone and Schatzberg interview
03:36     Disparity between effects on suicidal ideation and antidepressant ratings
05:36     Ethics of placebo and ketamine in patients with suicidal ideation
08:28     Immediate clinical implications
11:40     Limitations
14:10     Further research
16:19     Kalin interview
16:24     Tucciarone et al.
20:39     Rovers et al.
24:30     Jelen et al.
Transcript
Board-certified psychiatrists, if you're seeking meaningful inpatient work with real clinical autonomy, consider becoming the Clinical Director for a 16-bed behavioral health hospital in Fergus Falls or Bemidji, Minnesota. You'll lead a supportive interdisciplinary team, enjoy predictable work-life balance, and have opportunities for teaching and mentorship without RVU pressure or third-party billing. Learn more on APA's Career Center, JobCentral, by searching Direct Care and Treatment – State of Minnesota.
Direct Care and Treatment – State of Minnesota:  bit.ly/DCTClinicalDirector
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org

In this special episode of AJP Audio, AJP Editor-in-Chief Dr. Ned Kalin is joined by Dr. María Oquendo (Perelman School of Medicine at the University of Pennsylvania, Philadelphia), chair of APA's Future DSM Strategic Committee to discuss a series of commentaries published in the May issue of the Journal discussing the strategic vision for the future of DSM.
00:39   Oquendo interview
03:07   Size of the response
04:18   Feedback
06:04   Incorporating the feedback
07:57   Emphasizing science with a title change for DSM
10:18   A living document
12:35   Changes from previous versions of DSM
16:08   Changes in documentation and coding
18:51   Lived experience
20:02   Working with AJP
Links to the commentaries: 
Initial Strategy for the Future of DSM
María A. Oquendo, M.D., Ph.D., et al.
The Future of DSM: A Report From the Structure and Dimensions Subcommittee
Dost Öngür, M.D., Ph.D., et al.
The Future of DSM: Are Functioning and Quality of Life Essential Elements of a Complete Psychiatric Diagnosis?
Karen Drexler, M.D., et al.
The Future of DSM: Role of Candidate Biomarkers and Biological Factors
Bruce Cuthbert, Ph.D., et al.
The Future of DSM: A Strategic Vision for Incorporating Socioeconomic, Cultural, and Environmental Determinants and Intersectionality
Milton L. Wainberg, M.D., et al.
Transcript
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
How authors may submit their work.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org